Glucagon
Brand names: GlucaGen, Baqsimi (intranasal)
Glucagon is used for the emergency treatment of severe hypoglycaemia when intravenous access or oral carbohydrate is not possible. It is also used in beta-blocker overdose.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a hormone that mobilises hepatic glycogen, raising blood glucose; it is therefore ineffective when glycogen stores are depleted.
Prescribing in practice
- It is ineffective when hepatic glycogen is depleted, such as in starvation, significant liver disease or chronic alcohol use.
- Give oral carbohydrate once the person has recovered enough to swallow safely, to restore glycogen and prevent recurrence.
- It can be given by carers; seek emergency help if there is no response.
Monitoring
Monitor blood glucose and conscious level after administration, and observe for recurrence of hypoglycaemia.
Counselling the patient
- Carers should know how and when to use it, and how to call for emergency help.
- Once you are awake and able to swallow, take a longer-acting carbohydrate snack.
- Nausea and vomiting can occur after a dose.
Evidence & guidelines
Established emergency treatment for severe hypoglycaemia per the SPC and UK guidance.
Reference: JBDS Hypoglycaemia Guidelines; TOXBASE; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Glucagon is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.